CHRISTIAN LAUBSCHER: Open Payments
NPI 1255591095 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 41 payments from 15 companies in 2025. Trend: 2023 $1,624 · 2024 $2,704 · 2025 $1,509
Food & beverage: $1,185Education: $325
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $254 |
| Syndax Pharmaceuticals, Inc. | 6 | $236 |
| PharmaEssentia USA Corporation | 2 | $173 |
| ABBVIE INC. | 3 | $158 |
| Lilly USA, LLC | 2 | $136 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| SOBI, INC | 3 | $90 |
| Incyte Corporation | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Celgene Corporation | 2 | $51 |
Products named: BESREMI, Cresemba, VENCLEXTA, OJJAARA, Vonjo, JAKAFI, SCEMBLIX, DANZITEN.
Industry payments across FL — which companies pay providers there.
